Abstract
The authors discuss the California Institute for Regenerative Medicine’s focus on state, national, and international regulatory policy issues impacting basic research and translational medicine.
Keywords:
Clinical trials; Drug target; Genomics; Induced pluripotent stem cells.
MeSH terms
-
Academies and Institutes* / legislation & jurisprudence
-
Academies and Institutes* / organization & administration
-
Animals
-
California
-
Cooperative Behavior
-
Government Agencies* / legislation & jurisprudence
-
Government Agencies* / organization & administration
-
Humans
-
Interdisciplinary Communication
-
Models, Organizational
-
Organizational Objectives
-
Periodicals as Topic
-
Regenerative Medicine* / legislation & jurisprudence
-
Regenerative Medicine* / organization & administration
-
State Government*
-
Stem Cell Research* / legislation & jurisprudence
-
Translational Research, Biomedical* / legislation & jurisprudence
-
Translational Research, Biomedical* / organization & administration